2025 Annual Meeting | C135 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Date Tuesday 04/08/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | 6A

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jennifer Graves, MD, PhD

Topic(s) Child Neurology and Developmental Neurology, Multiple Sclerosis

Learning Objectives Participants should recognize key features of the biology, epidemiology and clinical expression of pediatric-onset MS; be able to formulate an approach to pediatric MS diagnosis and management, including the appropriate application of disease-modifying therapies and recognizing the impact on cognitive and emotional function; and be able to construct strategies for rehabilitation and physical activity and to mitigate the impact of social determinants of health.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Introduction and Overview Jennifer Graves, MD, PhD
07:05 AM - 07:50 AM PDT	Speaker	Unique Features and Treatment Considerations of Pediatric MS and Related Disorders Jennifer Graves, MD, PhD
07:50 AM - 08:35 AM PDT	Speaker	Pediatric MS: Causes and Consequences from an Ecological and Psychosocial Perspective Lauren B. Krupp, MD, FAAN
08:35 AM - 09:00 AM PDT	Q&A	Questions and Answers Jennifer Graves, MD, PhD, Lauren B. Krupp, MD, FAAN

Faculty Disclosures
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��